Craft Cannabis is the Future & Micro-Cultivators Will Lead the Way
December 3, 2021
Ryan Allway December 3rd, 2021 App, Exclusive, News, Top Story Canada’s legal cannabis industry is flooded with products that prioritize profits over quality. While many consumers are price-sensitive, Deloitte Canada found that 86% of Millennial and Gen Z consumers are willing to buy premium products. These trends mirror many... Read more
Ryan Allway October 15th, 2021 App, Exclusive, News, Top Story Cannabis-based pharmaceutical drug products remain a niche market despite the plant’s significant promise. By acting on the endocannabinoid system, a widespread neuromodulator that plays an important role in everything from central nervous system development to synaptic plasticity, cannabinoids have... Read more
Ketamine Offers Promise to Veterans with PTSD
September 24, 2021
Ryan Allway September 24th, 2021 App, Exclusive, Psychedelics, Top Story Post-traumatic stress disorder, or PTSD, is a common mental illness among veterans. According to the Department of Veteran Affairs, 11% to 30% of veterans who served in foreign wars experience PTSD, far higher than the estimated 6% of the... Read more
BioHarvest Provides Unmatched Consistency & Variety in Cannabis
September 14, 2021
Ryan Allway September 14th, 2021 App, Exclusive, News, Top Story The cannabis industry is quickly evolving from dried cannabis to beverages and other product formats. At the same time, the pharmaceutical industry is increasingly embracing cannabinoids for their potential therapeutic benefits. The challenge is converting raw plant material into... Read more
Big Data and AI Can Guide Cannabis Medicine
August 30, 2021
Robin Lefferts August 30th, 2021 App, Exclusive, News, Top Story In order for cannabis medicine to make the big leap to mainstream acceptance, a few things likely have to take place. Doctors, not just cannabis providers, need to become more comfortable discussing and prescribing the plant. Regulations need to... Read more
Ryan Allway August 20th, 2021 App, Exclusive, News, Top Story Nature is the lifeblood of the health and wellness industry. In fact, rainforest plants account for the raw material to produce a quarter of Western pharmaceuticals, including more than 120 different drugs. The challenge is understanding natural compounds and... Read more
Ryan Allway August 17th, 2021 App, Psychedelics, Top Story Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Silo Pharma Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S.... Read more
Ryan Allway July 22nd, 2021 Psychedelics, Top News VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased... Read more
Hempsana Signs Processing Agreement With New Leaf Canada
July 21, 2021
Ryan Allway July 21st, 2021 News, Top News Hempsana Holdings Ltd. (the “ Company ” or “ Hempsana ”) is pleased to announce the Company has signed a processing agreement with New Leaf Canada Inc. ( “New Leaf” ) to process 2,000kg of hemp to produce full spectrum CBD crude for revenue of up to... Read more
Rising Cannabis Extractor Going Public Today
July 15, 2021
Robin Lefferts July 15th, 2021 App, Exclusive, News, Top Story In the Canadian cannabis market, Cannabis 3.0 is finally starting to realize the sales potential many investors imagined back in 2019. That is when Canada legalized cannabis-derived products like oils, extracts, and edibles, and the thought was these new... Read more
